Drug
somatotropin
somatotropin is a pharmaceutical drug with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
50%(2 trials)
Phase Distribution
Ph phase_2
3
75%
Ph not_applicable
1
25%
Phase Distribution
0
Early Stage
3
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 2Efficacy & side effects
3(75.0%)
N/ANon-phased studies
1(25.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(4)
Detailed Status
Completed4
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 23 (75.0%)
N/A1 (25.0%)
Trials by Status
completed4100%
Recent Activity
0 active trials
Showing 4 of 4
completednot_applicable
Effect of Growth Hormone on Early Brain Development in Girls With Turner Syndrome
NCT01367834
completedphase_2
Pilot Study of Growth Hormon to Treat SMA Typ II and III
NCT00533221
completedphase_2
Growth Hormone Deficiency in Chronic Heart Failure: A Preliminary Trial
NCT00591760
completedphase_2
Long-Term Efficacy and Safety of Growth Hormone Replacement Therapy in Chronic Heart Failure
NCT01576861
Clinical Trials (4)
Showing 4 of 4 trials
NCT01367834Not Applicable
Effect of Growth Hormone on Early Brain Development in Girls With Turner Syndrome
NCT00533221Phase 2
Pilot Study of Growth Hormon to Treat SMA Typ II and III
NCT00591760Phase 2
Growth Hormone Deficiency in Chronic Heart Failure: A Preliminary Trial
NCT01576861Phase 2
Long-Term Efficacy and Safety of Growth Hormone Replacement Therapy in Chronic Heart Failure
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4